Surmodics, Inc. (SRDX) NASDAQ

29.94

-0.88(-2.86%)

Updated at September 26 04:00PM

Currency In USD

Surmodics, Inc.

Address

9924 West 74th Street

Eden Prairie, MN 55344-3523

United States of America

Phone

952 500 7000

Sector

Healthcare

Industry

Medical - Devices

Employees

389

First IPO Date

March 04, 1998

Key Executives

NameTitlePayYear Born
Mr. Gary R. MaharajChief Executive Officer, President & Director1.32M1963
Mr. Joseph J. StichSenior Vice President of Human Resources & President of In Vitro Diagnostics570,9201965
Mr. Gordon S. Weber J.D.Senior Vice President of Legal, General Counsel & Secretary596,6951964
Mr. Charles W. OlsonSenior Vice President & President of Medical Device Coatings604,1151964
Mr. Timothy J. ArensSenior Vice President of Finance & Information Technology and Chief Financial Officer644,5111967
Ms. Teryl L. W. SidesSenior Vice President & President of Vascular Interventions741,3701970
Mr. John D. MandersCorporate Controller, Vice President of Finance & Principal Accounting Officer01982
Joel SuiterDirector of Corporate Development0N/A

Description

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.